Contract Bidding Open For CILOSTAZOLE TAB 100 MG,CARBIMAZOLE 5 MG TAB,DULOXETINE 20 MG TAB,PAROXETINE XR 12 5 MG TAB,METHYLPR in PUNE, MAHARASHTRA
Bid Publish Date
24-Jun-2025, 3:56 pm
Bid End Date
15-Jul-2025, 4:00 pm
EMD
₹3,961
Location
Progress
RAQuantity
655608
Category
CILOSTAZOLE TAB 100 MG
Bid Type
Two Packet Bid
Categories
4
Indian Army has released a public tender for CILOSTAZOLE TAB 100 MG, CARBIMAZOLE 5 MG TAB, DULOXETINE 20 MG TAB, PAROXETINE XR 12 5 MG TAB, METHYLPREDNISOLONE 4 MG TAB, LEVODOPA 100 MG CARBIDOPA 25 MG SYNDOPA PLUS TAB, LAMIVUDINE 150 MG TAB, PYRIDOSTIGMINE 60 MG TAB, QUETIAPINE 50 MG TAB, SYRUP TERBUTALINE SULPHATE 1 25 MG BROMHEXINE HCL 4 MG GUAIPHENESIN 50 MG PER 5 ML BOTTLE OF 100 ML, MEMANTINE 5MG TAB, GLIBENCLAMIDE 5MG TAB, HYDROCHLORTHIAZIDE 12 5 MG TAB, ATORVASTATIN 10 MG ASPRIN 75 MG TAB in PUNE, MAHARASHTRA. Quantity: 655608. Submission Deadline: 15-07-2025 16: 00: 00. Download documents and apply online.
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
CILOSTAZOLE TAB 100 MG , CARBIMAZOLE 5 MG TAB , DULOXETINE 20 MG TAB , PAROXETINE XR 12 5 MG TAB , METHYLPREDNISOLONE 4 MG TAB , LEVODOPA 100 MG CARBIDOPA 25 MG SYNDOPA PLUS TAB , LAMIVUDINE 150 MG TAB , PYRIDOSTIGMINE 60 MG TAB , QUETIAPINE 50 MG TAB , SYRUP TERBUTALINE SULPHATE 1 25 MG BROMHEXINE HCL 4 MG GUAIPHENESIN 50 MG PER 5 ML BOTTLE OF 100 ML , MEMANTINE 5MG TAB , GLIBENCLAMIDE 5MG TAB , HYDROCHLORTHIAZIDE 12 5 MG TAB , ATORVASTATIN 10 MG ASPRIN 75 MG TAB
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-7818025.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
14 Items Sign in to view GEM price trends Sign in for GEM prices
CILOSTAZOLE TAB 100 MG
CILOSTAZOLE TAB 100 MG
CARBIMAZOLE 5 MG TAB
CARBIMAZOLE 5 MG TAB
DULOXETINE 20 MG TAB
DULOXETINE 20 MG TAB
PAROXETINE XR 12 5 MG TAB
PAROXETINE XR 12 5 MG TAB
METHYLPREDNISOLONE 4 MG TAB
METHYLPREDNISOLONE 4 MG TAB
LEVODOPA 100 MG CARBIDOPA 25 MG SYNDOPA PLUS TAB
LEVODOPA 100 MG CARBIDOPA 25 MG SYNDOPA PLUS TAB
LAMIVUDINE 150 MG TAB
LAMIVUDINE 150 MG TAB
PYRIDOSTIGMINE 60 MG TAB
PYRIDOSTIGMINE 60 MG TAB
QUETIAPINE 50 MG TAB
QUETIAPINE 50 MG TAB
SYRUP TERBUTALINE SULPHATE 1 25 MG BROMHEXINE HCL 4 MG GUAIPHENESIN 50 MG PER 5 ML BOTTLE OF 100 ML
SYRUP TERBUTALINE SULPHATE 1 25 MG BROMHEXINE HCL 4 MG GUAIPHENESIN 50 MG PER 5 ML BOTTLE OF 100 ML
MEMANTINE 5MG TAB
MEMANTINE 5MG TAB
GLIBENCLAMIDE 5MG TAB
GLIBENCLAMIDE 5MG TAB
HYDROCHLORTHIAZIDE 12 5 MG TAB
HYDROCHLORTHIAZIDE 12 5 MG TAB
ATORVASTATIN 10 MG ASPRIN 75 MG TAB
ATORVASTATIN 10 MG ASPRIN 75 MG TAB
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | CILOSTAZOLE TAB 100 MG | CILOSTAZOLE TAB 100 MG | 12,600 | no | [email protected] | 30 | |
| 2 | CARBIMAZOLE 5 MG TAB | CARBIMAZOLE 5 MG TAB | 29,940 | no | [email protected] | 30 | |
| 3 | DULOXETINE 20 MG TAB | DULOXETINE 20 MG TAB | 39,600 | no | [email protected] | 30 | |
| 4 | PAROXETINE XR 12 5 MG TAB | PAROXETINE XR 12 5 MG TAB | 15,000 | no | [email protected] | 30 | |
| 5 | METHYLPREDNISOLONE 4 MG TAB | METHYLPREDNISOLONE 4 MG TAB | 12,600 | no | [email protected] | 30 | |
| 6 | LEVODOPA 100 MG CARBIDOPA 25 MG SYNDOPA PLUS TAB | LEVODOPA 100 MG CARBIDOPA 25 MG SYNDOPA PLUS TAB | 64,800 | no | [email protected] | 30 | |
| 7 | LAMIVUDINE 150 MG TAB | LAMIVUDINE 150 MG TAB | 15,000 | no | [email protected] | 30 | |
| 8 | PYRIDOSTIGMINE 60 MG TAB | PYRIDOSTIGMINE 60 MG TAB | 15,000 | no | [email protected] | 30 | |
| 9 | QUETIAPINE 50 MG TAB | QUETIAPINE 50 MG TAB | 15,600 | no | [email protected] | 30 | |
| 10 | SYRUP TERBUTALINE SULPHATE 1 25 MG BROMHEXINE HCL 4 MG GUAIPHENESIN 50 MG PER 5 ML BOTTLE OF 100 ML | SYRUP TERBUTALINE SULPHATE 1 25 MG BROMHEXINE HCL 4 MG GUAIPHENESIN 50 MG PER 5 ML BOTTLE OF 100 ML | 5,868 | bott | [email protected] | 30 | |
| 11 | MEMANTINE 5MG TAB | MEMANTINE 5MG TAB | 11,400 | no | [email protected] | 30 | |
| 12 | GLIBENCLAMIDE 5MG TAB | GLIBENCLAMIDE 5MG TAB | 21,000 | no | [email protected] | 30 | |
| 13 | HYDROCHLORTHIAZIDE 12 5 MG TAB | HYDROCHLORTHIAZIDE 12 5 MG TAB | 240,000 | no | [email protected] | 30 | |
| 14 | ATORVASTATIN 10 MG ASPRIN 75 MG TAB | ATORVASTATIN 10 MG ASPRIN 75 MG TAB | 157,200 | no | [email protected] | 30 |
Required Documents
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Reverse Auction Schedule
Start
03-Aug-2025, 11:00 am
End
04-Aug-2025, 11:00 am
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 15-07-2025 14:28:49 | |
| 2 | ********** Under PMA | - | 15-07-2025 14:21:54 | |
| 3 | ********** Under PMA | - | 06-07-2025 16:27:28 | |
| 4 | ********** Under PMA | - | 15-07-2025 14:46:11 | |
| 5 | ********** Under PMA | - | 14-07-2025 13:37:22 | |
| 6 | ********** Under PMA | - | 15-07-2025 15:59:49 | |
| 7 | ********** Under PMA | - | 15-07-2025 14:35:17 | |
| 8 | ********** Under PMA | - | 14-07-2025 12:08:52 | |
| 9 | ********** Under PMA | - | 14-07-2025 18:20:16 | |
| 10 | ********** Under PMA | - | 14-07-2025 17:59:33 | |
| 11 | ********** Under PMA | - | 27-06-2025 13:21:10 | |
| 12 | ********** Under PMA | - | 13-07-2025 21:50:50 | |
| 13 | ********** Under PMA | - | 14-07-2025 18:37:53 | |
| 14 | ********** Under PMA | - | 10-07-2025 15:14:40 | |
| 15 | ********** Under PMA | - | 15-07-2025 15:37:26 | |
| 16 | ********** Under PMA | - | 15-07-2025 12:57:31 | |
| 17 | ********** Under PMA | - | 14-07-2025 17:26:34 | |
| 18 | ********** Under PMA | - | 15-07-2025 14:57:21 | |
| 19 | ********** Under PMA | - | 13-07-2025 23:52:24 | |
| 20 | ********** Under PMA | - | 08-07-2025 18:32:13 | |
| 21 | ********** Under PMA | - | 14-07-2025 13:37:47 |
Frequently Asked Questions
Key insights about MAHARASHTRA tender market
What are the eligibility requirements for participating in this tender?
The eligibility requirements include being a registered entity with the authority to manufacture and supply pharmaceutical products. Additionally, bidders need to demonstrate prior experience in similar contracts and compliance with relevant regulatory standards to qualify for submission.
What certificates are required to fulfill the tender requirements?
Bidders must submit various certificates, including manufacturing licenses, drug registration certificates, and ISO certifications. These documents should verify compliance with quality and safety standards pertinent to pharmaceutical products.
How do I register for submitting bids for the tender?
To register for the submission process, entities must create an account on the official e-procurement portal. Detailed instructions for the registration process can be found in the tender documentation and will guide you through the necessary steps.
What are the payment terms associated with the tender?
The payment terms will be negotiated upon selection and will include comprehensive details on timelines for payment releases following the satisfactory fulfillment of delivery and compliance with quality standards.
What considerations are made for MSEs or startups in this tender?
The tender ensures benefits for Micro, Small, and Medium Enterprises (MSEs), encouraging their engagement by allowing them special quotas or price evaluation considerations. Startups are also encouraged to participate, supporting local entrepreneurs to tender their products and services.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 4
GeM-Bidding-7818025.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS